Heterogeneity of bcl‐2 expression in MALT lymphoma

Histopathology

Volumn 26, Issue 1, 1995, Pages 75-78

  ASHTON KEY M ^a   BIDDOLPH, S C ^a   STEIN, H ^b   GATTER, K C ^a   MASON, D Y ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

bcl 2; heterogeneous expression; MALT lymphomas

Indexed keywords

GROWTH FACTOR;

ARTICLE; B CELL LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHATIC TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

GASTROINTESTINAL NEOPLASMS; HUMAN; IMMUNOENZYME TECHNIQUES; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLAND NEOPLASMS; THYROID NEOPLASMS;

EID: 0028953010     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1995.tb00624.x     Document Type: Article

References (17)

1. Malignant lymphoma of mucosaassociated lymphoid tissue.
2. Extranodal malignant lymphoma arising from mucosa‐associated lymphoid tissue.
3. Primary B‐cell gastric lymphoma—a reassessment of its histogenesis.
4. Lymphomas of mucosa‐associated lymphoid tissue (MALT).
5. Primary B‐cell gastric lymphoma: a clinicopathological study of 145 patients.
6. Relationship between high‐grade lymphoma and low‐grade B‐cell mucosa‐associated lymphoid tissue lymphoma (MALToma) of the stomach.
7. Bcl‐2 is an inner mitochondrial membrane protein that blocks programmed cell death.
8. Expression of the bcl‐2 oncogene protein is not specific for the 14:18 chromosomal translocation.
9. Expression of the bcl‐2 gene product in follicular lymphoma.
10. Different bcl‐2 protein expression in high‐grade B‐cell lymphomas derived from lymph node or mucosa‐associated lymphoid tissue.
11. Antigen retrieval in formalin‐fixed, paraffin‐embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.
12. The avidin‐biotin complex in immunology.
13. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti‐alkaline phosphatase (APAAP complexes).
14. Bcl‐2 expression in lymphomas [letter; comment].
15. al e. p53 and bcl‐2 expression in high grade B cell lymphomas: correlation with survival time.
16. Heterogeneity of CD3 antigen in T cell lymphomas.
17. The expression of the CD3 antigen in Hodgkin's disease.